• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Estimating Vaccine Effectiveness by Linking Population-Based Health Registries: Some Sources of Bias.基于人群健康登记系统估计疫苗有效性:一些偏倚来源。
Am J Epidemiol. 2022 Oct 20;191(11):1975-1980. doi: 10.1093/aje/kwac145.
2
The impact of underreported infections on vaccine effectiveness estimates derived from retrospective cohort studies.漏报感染对回顾性队列研究得出的疫苗效力估计的影响。
Int J Epidemiol. 2024 Apr 11;53(3). doi: 10.1093/ije/dyae077.
3
COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infections, COVID-19 related hospitalizations and deaths, among individuals aged ≥65 years in Portugal: A cohort study based on data-linkage of national registries February-September 2021.COVID-19 疫苗对≥65 岁人群中出现症状的 SARS-CoV-2 感染、COVID-19 相关住院和死亡的有效性:基于国家登记数据链接的 2021 年 2 月至 9 月的队列研究。
PLoS One. 2022 Sep 13;17(9):e0274008. doi: 10.1371/journal.pone.0274008. eCollection 2022.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis.新冠疫苗的真实世界有效性:文献综述和荟萃分析。
Int J Infect Dis. 2022 Jan;114:252-260. doi: 10.1016/j.ijid.2021.11.009. Epub 2021 Nov 17.
6
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.在德尔塔和奥密克戎变异株流行期间,mRNA 疫苗加强针在成年人中的 COVID-19 相关急诊和紧急护理就诊和住院方面的效果 - VISION 网络,10 个州,2021 年 8 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(4):139-145. doi: 10.15585/mmwr.mm7104e3.
7
Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway.在挪威甲型 H1N1pdm09 流感大流行期间,使用健康登记数据评估疫苗效果的实用性。
BMC Infect Dis. 2012 Mar 20;12:63. doi: 10.1186/1471-2334-12-63.
8
Using observational epidemiology to evaluate COVID-19 vaccines: integrating traditional methods with new data sources and tools.利用观察性流行病学评估 COVID-19 疫苗:将传统方法与新数据源和工具相结合。
Can J Public Health. 2021 Oct;112(5):867-871. doi: 10.17269/s41997-021-00554-z. Epub 2021 Jun 23.
9
Sources of bias in observational studies of covid-19 vaccine effectiveness.新冠病毒 19 疫苗有效性观察性研究中的偏倚来源。
J Eval Clin Pract. 2024 Feb;30(1):30-36. doi: 10.1111/jep.13839. Epub 2023 Mar 26.
10
Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021.腺病毒 5 型载体疫苗和灭活 COVID-19 疫苗对由 B.1.617.2(德尔塔)变异株引起的有症状 COVID-19、COVID-19 肺炎和重症 COVID-19 的有效性:来自中国云南 2021 年暴发疫情的证据。
Vaccine. 2022 May 3;40(20):2869-2874. doi: 10.1016/j.vaccine.2022.03.067. Epub 2022 Apr 1.

引用本文的文献

1
Bias and negative values of COVID-19 vaccine effectiveness estimates from a test-negative design without controlling for prior SARS-CoV-2 infection.从未控制 SARS-CoV-2 既往感染的病例对照设计中估算的 COVID-19 疫苗效力的偏倚和负值。
Nat Commun. 2024 Nov 20;15(1):10062. doi: 10.1038/s41467-024-54404-w.
2
Biases in COVID-19 vaccine effectiveness studies using cohort design.使用队列设计的COVID-19疫苗有效性研究中的偏倚。
Front Med (Lausanne). 2024 Oct 30;11:1474045. doi: 10.3389/fmed.2024.1474045. eCollection 2024.
3
The impact of underreported infections on vaccine effectiveness estimates derived from retrospective cohort studies.漏报感染对回顾性队列研究得出的疫苗效力估计的影响。
Int J Epidemiol. 2024 Apr 11;53(3). doi: 10.1093/ije/dyae077.

基于人群健康登记系统估计疫苗有效性:一些偏倚来源。

Estimating Vaccine Effectiveness by Linking Population-Based Health Registries: Some Sources of Bias.

出版信息

Am J Epidemiol. 2022 Oct 20;191(11):1975-1980. doi: 10.1093/aje/kwac145.

DOI:10.1093/aje/kwac145
PMID:35938874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9384684/
Abstract

The coronavirus disease 2019 (COVID-19) pandemic has underscored the importance of observational studies of real-world vaccine effectiveness (VE) to help answer urgent public health questions. One approach to rapidly answering questions about real-world VE relies on linking data from a population-based registry of vaccinations with a population-based registry of health outcomes. Here we consider some potential sources of bias in linked registry studies, including incomplete reporting to the registries, errors in linking individuals between registries, and errors in the assumed population size of the catchment area of the registries. We show that the direction of the bias resulting from one source of error by itself is predictable. However, if multiple sources of error are present, the direction of the bias can be either upward or downward. The biases can be so strong as to make harmful vaccines appear effective. We provide explicit formulas with which to quantify and adjust for multiple biases in estimates of VE which could be used in sensitivity analyses. While this work was motivated by COVID-19 vaccine questions, the results are generally applicable to studies that link population-based exposure registries with population-based case registries to estimate relative risks of exposures.

摘要

2019 年冠状病毒病(COVID-19)大流行突显了观察性研究在现实世界疫苗有效性(VE)方面的重要性,以帮助回答紧迫的公共卫生问题。一种快速回答有关现实世界 VE 的问题的方法是依赖于将疫苗接种的基于人群的登记处的数据与基于人群的健康结果登记处的数据进行链接。在这里,我们考虑了链接登记处研究中一些潜在的偏倚来源,包括向登记处不完全报告、在登记处之间链接个体时的错误以及登记处的集水区的假定人口规模的错误。我们表明,仅由一个来源的错误引起的偏倚的方向是可预测的。然而,如果存在多个错误来源,则偏倚的方向可以是向上或向下。这些偏倚可能非常强烈,以至于使有害疫苗看起来有效。我们提供了明确的公式,可以量化和调整 VE 估计中的多个偏倚,这些偏倚可用于敏感性分析。虽然这项工作是由 COVID-19 疫苗问题驱动的,但结果通常适用于将基于人群的暴露登记处与基于人群的病例登记处相链接以估计暴露的相对风险的研究。